Paul B. Manning - 05 Jul 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Director, 10%+ Owner
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
05 Jul 2022
Net transactions value
+$9,999,998
Form type
4
Filing time
05 Jul 2022, 16:10:11 UTC
Previous filing
22 Jun 2022
Next filing
17 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $9,999,998 +4,761,904 +54% $2.10 13,651,128 05 Jul 2022 Direct F1
holding VRCA Common Stock 1,481,719 05 Jul 2022 See footnote F2
holding VRCA Common Stock 256,634 05 Jul 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Mr. Manning jointly with his spouse.
F2 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has shared voting and investment power with respect to the shares held by BKB.
F3 The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.